Ronald Blue Trust, Inc. Novo Nordisk A S Transaction History

Ronald Blue Trust, Inc.

$7.68 Billion
Q1 2025

A detailed history of Ronald Blue Trust, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 20,466 shares of NVO stock, worth $1.19 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

20,466

Previous 16,562 23.57%

Holding current value

$1.19 Million

Previous $1.42 Million 0.21%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	BUY	$69.3 - $90.95 $270,547 - $355,068	3,904 Added 23.57%	20,466 $1.42 Million
Q4 2024 Jan 30, 2025	SELL	$85.0 - $120.04 $1.19 Million - $1.68 Million	-14,005 Reduced 45.82%	16,562 $1.42 Million
Q4 2024 Jan 22, 2025	BUY	$85.0 - $120.04 $668,440 - $943,994	7,864 Added 34.64%	30,567 $2.63 Million
Q3 2024 Oct 17, 2024	BUY	$119.07 - $145.42 $785,742 - $959,626	6,599 Added 40.98%	22,703 $2.7 Million
Q2 2024 Jul 18, 2024	BUY	$122.71 - $146.91 $1.27 Million - $1.53 Million	10,381 Added 181.39%	16,104 $2.3 Million
Q1 2024 May 01, 2024	SELL	$102.11 - $135.92 $337,677 - $449,487	-3,307 Reduced 36.62%	5,723 $734,000
Q4 2023 Jan 18, 2024	BUY	$87.78 - $105.45 $443,113 - $532,311	5,048 Added 126.77%	9,030 $821,000
Q3 2023 Oct 11, 2023	BUY	$90.94 - $199.54 $161,236 - $353,784	1,773 Added 80.26%	3,982 $644,000
Q2 2023 Jul 14, 2023	SELL	$155.98 - $172.65 $1.1 Million - $1.22 Million	-7,044 Reduced 76.13%	2,209 $352,000
Q1 2023 Apr 17, 2023	SELL	$132.34 - $159.14 $75,830 - $91,187	-573 Reduced 5.83%	9,253 $1.25 Million
Q4 2022 Jan 17, 2023	BUY	$102.55 - $135.33 $465,064 - $613,721	4,535 Added 85.71%	9,826 $979,000
Q3 2022 Oct 21, 2022	BUY	$95.28 - $116.93 $92,802 - $113,889	974 Added 22.56%	5,291 $590,000
Q2 2022 Aug 09, 2022	BUY	$103.24 - $121.81 $445,687 - $525,853	4,317 New	4,317 $480,000

Others Institutions Holding NVO

# of Institutions

1,867

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $132B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.

Account

Ronald Blue Trust, Inc. Novo Nordisk A S Transaction History